ILSI Mission Statement
The mission of ILSI is to research, develop, and advocate policies and actions that promote biomedical science, biotechnology, Ag-Biotech and medical device innovation in the State of Israel.
- Create a favorable environment for the State's biomedical and health care technology community to discover, produce, and deliver products that benefit society.
- Provide a forum to identify, analyze, and develop positions on public policy issues that affect Israel's biomedical and health care technology interests.
- Provide a forum that will allow the Life Science industry a platform from which it an exhibit its innovation, exuberance and growth to the international markets and healthcare players.
- Communicate to public officials, providers, patients, and the general public the value embedded in the Israeli life science technology community as a contributor to both health and economic growth.
Snap Shot of ILSI
The Israel Life Science Industry or ILSI is composed of medical device, biotechnology, pharmaceutical and medical service companies, universities and private research institutions, and providers of services to the industry such as venture capitalists, lawyers, accountants and incubators.
The goal of ILSI is to develop solid information about the medical research and manufacturing community in Israel, and to make that information available to political leaders, the news media, venture capitalists, investment bankers, and the public. It is exactly this information required by potential investors be it strategic corporate players or financial investors worldwide.
The intent is to demonstrate that medical research and manufacturing is a major contributor to Israel’s economy - with unusually great potential for financial growth and job creation.
Israel can boast some of the world's finest scientific works. By demonstrating a firm correlation between the academia, medical institutions and industry, ILSI assures potential investors that dynamic entrepreneurship is backed by great science. In fact, Israel is ranked second and third in terms of number of publications in leading life science magazines per 100,000 inhabitants and senior faculty members per million inhabitants, respectively.
ILSI provides the life science community a strong voice with which to communicate with Public officials both in Israel and abroad. Is only when one exhibits size and united strength one can hope to affect a desirable change in policies and attitudes.
- Enhance interaction and provide a unified voice for its members.
- Act as a single source from which members and scientists can obtain professional and organizational information.
- Disseminate scientific information to and provide opportunities for networking between companies, potential investors, and other interested parties.
- Provide forums for the academic community and the health care technology industry, to foster innovation and technology.
- Identify and attract funds for companies for the development of research infrastructure and facilities.
- Develop strategies to encourage university and hospital researchers to get their products to the market and create ways to commercialize the scientific know-how.
- Provide a forum to identify, analyze and develop positions on public policy issues that affect Israel’s biomedical and health care technology interests and propose policies and actions that promote technology development.
- Develop solid information about the medical research and manufacturing community and make that information available to political leaders, the news media, venture capitalists, investment bankers and the public.
- Develop data to demonstrate that Israel has the scientific and technological base, environment and business climate required to realize far greater potential.
ILSI is a registered non-profit corporation no. 580433985
For more information: http://www.ilsi.org.il/
A pioneer in Professional Congress Organization and Association Management, Kenes continues to uphold its 45-year tradition as a leading innovator in its field.
Founded in 1965, Kenes is widely regarded as an industry pioneer. Today with more than 45 years experience, the company is committed to providing the highest standard of service to medical and scientific associations, aiding in the facilitation of global exchange and management of medical knowledge.
Kenes has organized over 2,800 congresses in over 100 countries, attracts around 110,000 attendees per year, and some 50 long-term clients. The company provides association management and consultancy services to 14 medical and scientific organizations with a combined 15,000 membership.
A global company with a local presence, Kenes has offices in Geneva, London, Munich, Hamburg, Berlin, Leipzig, Madrid, Istanbul, Tel-Aviv, Singapore, and Santiago de Chile. A staff of over 300 specialists worldwide ensurses that Kenes' experience, expertise, values and ethics are upheld throughout the Group.
Since 1972, Kenes has been a member of ICCA (the International Congress and Convention Association), and of IAPCO (the International Association of Professional Congress Organizers) of which Gideon Rivlin, Kenes Founder, served as president from 1981 to 1983.
For more information www.kenes.com